Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ACLY	"ACL, ATPCL, CLATP"	ENSG00000131473	"ATP citrate lyase"	P53396	17	41866917-41930542	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007783, HPA022434, HPA022953, HPA022959, HPA028758"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		3100000	"Cluster 44: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.94e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (3.38e-3)"	"unprognostic (4.11e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.67e-3)"	64.9	30.2	24.0	43.9	27.2	34.7	46.7	33.6	55.5	33.2	22.5	35.4	49.3	34.4	34.7	30.5	36.0	31.1	27.1	24.7	66.5	47.5	27.5	35.3	42.7	80.3	48.6	21.3	46.3	37.4	22.4	42.4	76.5	62.6	35.7	23.2	39.1	28.5	15.3	28.9	43.7	42.5	34.2	39.1	38.9	32.2	43.1	48.4	30.8	14.9	40.3	36.7	29.2	43.7	127.1	423.2	194.8	168.8	296.1	274.4	178.3	174.0	188.0	213.7	266.3	217.9	141.8	204.7	108.8	245.2	200.6	197.2	253.9	298.0	177.8	184.9	243.0	117.3	228.3	227.5	136.9	191.9	147.1	219.8	88.3	376.9	75.6	140.0	228.7	155.0	147.4	158.5	180.4	130.0	317.8	107.6	127.6	84.8	75.7	205.2	236.2	262.2	221.0	222.4	364.7	200.2	124.5	382.8	133.7	167.6	229.4	181.0	248.4	165.7	135.5	169.0	291.0	91.9	127.0	193.0	280.3	145.7	137.5	32.2	29.2	36.5	30.9	30.9	29.1	21.6	24.4	27.7	33.0	18.3	18.1	20.3	14.6	24.0	39.8	19.1	34.3	33.8	24.0	27.2	33.6	55.5	24.7	66.5	80.3	48.6	76.5	34.2	43.1	43.7	28.2	28.9	26.2	12.4	20.5	25.0	10.0	25.4	12.5	12.1	38.6	21.6	12.6	31.5	21.0	23.9	4.2	22.6	25.9	26.7	11.7	33.8	73.3	31.6	35.3	33.4	65.9	34.3	10.9	33.6	46.5	28.9	23.4	29.2	15.2	28.7	41.4	53.0	31.0	18.5	14.7	54.0	20.3	39.0	25.9	17.5	61.8	27.6	32.0	16.9	42.9	7.6	25.7	11.6	13.6	42.9	16.2	51.1	17.4	35.9	40.4	87.0	31.1	9.4	13.1	17.6	25.7	17.9	36.0	21.6	33.0	22.2	25.1	49.0	22.2	15.5
ACO1	"IREB1, IREBP, IRP1"	ENSG00000122729	"Aconitase 1"	P21399	9	32384603-32454769	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Lyase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 134.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 194.4;Proximal tubular cells: 183.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 194.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019371, HPA024157"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA		10000000	"Cluster 38: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Mitochondria, Cytosol"		"HPA019371: AB_1844519, HPA024157: AB_1844520"	"unprognostic (2.11e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (5.73e-5)"	"unprognostic (2.54e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-2)"	96.6	50.5	15.2	16.1	15.4	3.5	50.1	14.6	15.3	19.8	19.1	23.7	48.6	19.2	30.2	15.4	14.6	15.6	36.3	14.0	16.2	89.2	134.5	20.3	8.8	15.8	15.8	17.4	37.6	22.8	13.1	16.1	14.9	21.9	20.6	12.9	16.6	19.1	25.1	12.0	35.8	22.9	15.3	9.3	28.7	17.6	16.9	13.6	34.5	37.8	7.1	24.4	13.7	14.1	37.5	33.7	25.7	40.7	194.5	104.8	11.6	69.3	169.1	31.2	24.5	36.0	11.4	7.4	21.6	73.1	84.9	5.1	51.3	66.3	62.3	23.8	13.8	54.7	33.4	39.3	97.4	5.1	21.2	91.7	20.1	80.4	56.1	95.6	81.7	28.4	20.0	15.7	89.9	9.9	29.5	26.4	26.9	23.3	35.5	22.8	38.0	7.8	118.9	34.1	3.3	10.5	71.9	2.8	7.6	27.1	16.7	13.5	89.2	112.5	38.2	38.2	18.2	7.8	15.5	14.7	78.7	18.2	10.2	33.2	11.3	3.3	9.2	11.3	8.0	5.6	6.2	6.9	9.3	5.0	8.1	8.2	1.2	6.7	10.0	4.3	3.9	8.4	15.2	15.4	14.6	15.3	14.0	16.2	15.8	15.8	14.9	15.3	16.9	14.1	16.3	3.2	25.7	43.8	6.7	4.5	7.9	11.9	9.1	21.4	17.8	7.4	45.5	38.6	11.7	23.9	22.9	50.8	6.2	26.4	19.6	19.0	8.7	10.0	30.7	18.7	4.9	11.6	24.6	41.0	22.1	29.7	39.3	13.9	2.5	17.1	15.7	194.4	15.1	33.7	46.5	27.7	10.2	14.8	6.7	6.9	23.6	15.6	7.2	20.6	8.6	25.7	8.2	22.1	24.1	19.4	23.7	23.3	7.2	10.1	56.1	183.4	10.7	14.3	19.7	30.5	22.2	9.8	19.4	10.3	5.4	53.5	7.5	22.2	34.6	8.7
ACO2	ACONM	ENSG00000100412	"Aconitase 2"	Q99798	22	41447830-41529273	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Lyase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 567.7;skeletal muscle: 660.4;tongue: 695.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 374.2;Proximal tubular cells: 285.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001097	Enhanced	Approved	Approved	Mitochondria		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA001097: AB_1078092"	"unprognostic (1.95e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.07e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.46e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.12e-2)"	88.8	81.6	154.2	38.6	152.2	32.0	52.4	153.0	190.0	39.5	160.1	94.4	162.9	42.0	26.1	60.4	53.6	36.5	567.7	155.2	153.1	138.9	73.9	40.7	40.5	146.1	145.3	30.8	53.8	233.8	33.6	30.5	147.8	41.2	69.6	46.9	72.0	49.5	660.4	45.5	158.5	43.7	152.5	44.7	110.2	35.1	186.3	38.0	53.7	695.8	43.3	52.5	42.4	159.6	47.2	55.8	56.5	116.3	101.2	69.8	78.7	43.7	60.9	79.0	71.9	81.2	63.5	115.7	72.2	70.6	60.3	109.8	108.8	88.3	42.8	75.8	80.2	51.0	73.7	95.0	86.7	147.8	77.8	120.8	64.4	78.9	83.2	61.7	81.2	61.5	72.9	118.4	65.4	91.7	73.7	47.9	37.0	282.6	115.1	102.3	37.8	162.1	106.8	97.3	37.8	33.9	112.2	128.7	82.0	44.9	74.9	74.7	55.5	60.0	68.7	50.2	45.0	64.7	92.1	80.6	102.0	64.0	66.5	10.3	52.9	18.1	32.0	76.4	29.3	49.4	25.5	34.9	69.0	46.4	29.2	30.8	9.0	39.4	97.1	24.0	41.2	58.6	154.2	152.2	153.0	190.0	155.2	153.1	146.1	145.3	147.8	152.5	186.3	159.6	26.3	25.6	31.8	45.4	49.4	18.7	54.5	102.7	31.3	60.6	28.0	23.2	9.1	64.3	63.5	60.7	81.3	100.3	33.3	190.8	131.0	58.3	14.5	37.2	17.7	26.1	53.2	30.3	28.8	42.6	60.0	24.0	77.5	37.1	40.6	56.7	20.7	64.6	91.5	53.8	34.0	99.1	89.5	35.5	26.4	8.9	24.2	39.2	35.6	7.5	68.3	73.9	34.0	12.1	20.9	43.9	103.5	27.8	63.2	34.4	374.2	285.7	59.2	73.5	59.2	28.6	38.4	26.4	38.2	35.8	16.1	193.2	30.7	54.4	113.6	64.9
CS		ENSG00000062485	"Citrate synthase"	O75390	12	56271699-56300391	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Tricarboxylic acid cycle"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 550.1;tongue: 600.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 239.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754"	Enhanced		Enhanced	Mitochondria		NA	NA		670000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB075750: AB_2665756, CAB075751: AB_2665757, CAB075752: AB_2665758, CAB075753: AB_2665759, CAB075754: AB_2665760, HPA038460: AB_2676023, HPA038461: AB_2676024"	"unprognostic (7.67e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.97e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	154.2	93.6	29.2	61.7	30.0	111.0	66.3	33.7	49.9	55.4	40.5	110.1	97.7	56.4	32.2	95.6	58.3	42.4	319.3	30.9	34.6	86.6	39.0	58.0	67.2	39.4	32.0	56.0	61.5	127.6	28.9	45.7	39.4	59.0	124.1	128.9	73.7	60.5	550.1	70.5	81.2	77.5	22.5	49.0	66.5	24.4	41.0	69.4	53.0	600.7	106.1	70.2	58.2	31.6	168.9	176.8	141.6	198.2	188.4	173.8	93.3	136.9	132.0	231.1	160.6	271.2	158.2	322.9	128.2	172.6	99.3	182.1	396.8	200.8	234.9	109.3	200.2	222.9	136.1	261.4	107.3	288.4	166.6	188.2	201.6	182.4	232.0	202.2	268.6	163.7	233.2	193.7	214.7	160.8	229.8	121.9	117.5	128.0	247.8	222.3	167.1	247.6	166.2	194.6	189.3	125.2	175.2	251.7	157.7	137.5	297.6	174.3	178.3	127.1	165.3	167.4	147.4	124.5	200.4	206.2	120.4	206.4	119.5	59.6	73.3	205.7	47.0	93.0	61.9	60.6	56.5	45.1	119.3	51.8	59.2	47.9	31.3	51.6	94.0	65.6	63.4	71.2	29.2	30.0	33.7	49.9	30.9	34.6	39.4	32.0	39.4	22.5	41.0	31.6	14.5	16.0	39.5	32.3	31.6	39.0	23.5	26.9	46.7	22.8	38.3	29.7	239.9	15.7	21.5	12.9	62.6	18.5	24.1	66.9	35.2	32.5	6.6	25.1	31.5	27.2	16.9	36.0	21.5	45.1	31.3	25.8	42.3	53.5	27.9	21.3	18.9	29.7	34.3	10.1	24.6	43.9	20.3	39.4	35.0	4.8	20.2	34.6	10.6	9.4	44.8	16.7	16.5	18.6	18.8	44.6	35.7	19.9	46.7	33.1	50.4	22.0	14.9	38.3	13.1	27.8	38.2	29.7	25.8	74.8	52.1	16.8	25.8	32.0	71.3	34.5
DLAT	"DLTA, E2, PDC-E2"	ENSG00000150768	"Dihydrolipoamide S-acetyltransferase"	P10515	11	112025408-112064404	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 89.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 100.5;Distal tubular cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003782, HPA040786, HPA062766"	Supported		Supported	Mitochondria		NA	NA		44000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864"	"unprognostic (4.57e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (6.19e-6)"	"unprognostic (7.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.70e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (8.68e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.23e-3)"	"unprognostic (6.25e-2)"	"prognostic favorable (1.95e-14)"	"unprognostic (5.82e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.15e-2)"	24.7	16.5	7.7	13.3	8.3	7.9	14.5	9.5	9.3	11.0	10.4	24.7	18.3	10.0	13.4	19.5	13.0	8.5	69.4	8.1	11.1	33.8	15.5	11.7	16.1	8.3	8.9	9.5	6.8	31.7	8.5	13.1	9.7	14.5	26.0	10.8	16.8	14.8	75.4	10.3	16.5	13.4	8.2	9.9	14.3	9.9	9.4	12.7	20.2	89.4	18.2	14.2	8.1	8.0	18.7	16.4	28.2	34.4	41.6	30.5	26.5	26.6	18.2	34.8	38.7	52.8	56.7	85.4	46.0	28.7	42.6	41.0	65.7	34.2	38.9	27.3	30.2	51.9	17.9	39.2	29.0	64.9	26.6	36.9	37.7	32.0	35.2	24.2	33.9	41.7	88.4	42.6	41.2	16.6	25.4	66.9	30.3	58.6	35.4	45.4	38.0	93.3	64.4	21.4	51.2	27.8	30.7	93.4	20.5	30.9	67.4	42.9	17.8	29.1	29.1	29.1	33.0	11.1	19.4	127.5	7.7	73.0	22.7	9.1	3.8	3.0	4.3	5.8	5.4	5.6	4.9	5.1	5.8	4.0	5.6	5.1	0.3	4.7	6.1	4.5	5.8	5.0	7.7	8.3	9.5	9.3	8.1	11.1	8.3	8.9	9.7	8.2	9.4	8.0	7.6	12.8	14.5	15.3	13.8	11.2	9.2	18.2	14.2	8.1	9.2	5.8	100.5	15.7	13.2	11.0	0.0	21.2	6.4	26.3	74.3	18.7	3.9	15.8	11.6	9.6	17.3	18.1	18.0	11.4	39.6	11.7	11.7	12.1	3.8	13.5	7.5	15.5	18.7	8.4	24.4	17.8	24.4	8.8	7.5	3.2	6.2	9.5	17.8	9.4	16.7	10.4	4.1	11.1	19.7	14.1	9.2	10.9	19.4	7.0	19.0	37.6	30.3	11.1	0.0	14.2	19.9	25.1	18.3	21.1	9.8	17.4	8.5	26.3	26.7	9.3
DLD	"DLDH, E3, GCSL, LAD, OGDC-E3"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107891162-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 357.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 356.2;Distal tubular cells: 226.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA044849: AB_2679111"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favorable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	108.7	98.9	22.7	42.1	23.7	54.0	49.0	27.1	29.1	36.3	35.6	109.0	81.8	45.3	21.2	94.1	34.3	48.5	264.1	23.1	29.5	153.3	112.8	39.3	50.1	27.1	27.4	30.0	49.2	136.7	27.8	43.1	26.6	45.7	99.3	35.0	50.2	50.3	295.0	38.9	71.9	67.7	24.9	38.4	80.5	31.3	25.7	43.2	64.2	357.0	67.5	66.1	32.7	23.4	171.4	134.5	74.8	127.9	104.6	91.4	88.4	96.5	80.8	110.6	86.2	159.5	95.5	165.9	159.6	103.0	177.7	110.9	150.2	135.8	166.1	111.1	88.4	116.9	175.6	116.7	80.3	194.7	116.0	104.8	97.6	116.4	63.4	72.3	134.0	137.0	298.5	119.7	121.8	188.1	161.8	138.9	87.4	206.0	98.2	113.1	117.8	225.9	151.8	250.8	92.3	99.9	156.3	262.1	143.9	149.9	100.5	165.8	87.9	120.7	97.3	238.1	149.4	89.3	187.1	114.6	115.0	204.1	130.2	132.7	63.9	136.0	46.9	81.6	49.4	37.8	46.8	46.8	87.2	38.5	47.9	50.5	39.9	68.1	116.9	29.9	49.0	64.2	22.7	23.7	27.1	29.1	23.1	29.5	27.1	27.4	26.6	24.9	25.7	23.4	26.7	28.9	20.7	14.7	26.3	31.4	42.7	124.7	31.3	47.1	24.0	19.2	356.2	51.5	70.5	79.1	22.9	110.2	27.3	56.1	226.9	69.3	10.2	27.6	26.2	32.2	30.6	53.9	23.9	55.9	62.7	36.3	36.7	28.0	26.6	35.3	26.0	86.8	69.2	21.9	25.3	44.1	114.0	41.0	26.5	7.3	23.3	37.5	37.4	15.9	62.2	36.0	38.1	21.1	16.7	42.6	51.4	42.2	30.7	24.3	60.0	178.9	55.5	45.5	26.3	28.4	44.8	55.2	51.5	48.0	32.4	108.4	29.5	73.7	78.7	39.2
DLST	"DLTS, KGD2, OGDC-E2"	ENSG00000119689	"Dihydrolipoamide S-succinyltransferase"	P36957	14	74881891-74903743	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003010	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		70000	"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA003010: AB_1078679"	"unprognostic (1.62e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.13e-12)"	"unprognostic (3.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.55e-3)"	64.5	85.5	33.5	32.3	34.7	75.0	59.6	35.8	34.7	62.1	43.8	63.3	58.7	47.5	43.2	62.9	46.1	36.2	129.0	30.8	35.1	100.4	78.4	48.5	36.9	35.8	34.5	45.8	44.8	78.8	35.4	44.8	34.3	41.3	59.3	37.1	46.5	43.5	144.7	64.3	58.3	52.1	33.6	46.1	57.7	29.3	37.3	42.5	42.9	224.2	45.7	58.0	49.7	32.5	79.1	81.1	63.7	45.4	98.1	110.6	97.5	106.3	107.8	106.8	99.0	80.9	88.1	81.0	44.3	118.1	48.1	87.8	109.0	105.6	112.0	61.5	43.3	68.4	66.3	74.8	101.4	49.5	45.4	114.0	90.5	103.8	126.7	95.5	106.1	36.6	53.4	55.6	110.3	112.0	59.0	69.7	55.0	146.6	79.0	73.8	93.8	46.7	125.8	100.8	75.5	64.1	100.6	129.4	71.3	54.2	121.7	70.5	90.8	63.8	83.2	79.5	74.0	38.7	43.7	73.4	93.9	47.9	68.8	3.0	1.3	2.3	2.1	2.0	1.8	1.6	1.9	1.6	2.1	1.0	1.5	2.2	1.3	3.5	1.8	2.8	2.0	1.5	33.5	34.7	35.8	34.7	30.8	35.1	35.8	34.5	34.3	33.6	37.3	32.5	24.2	6.4	4.8	14.0	22.7	26.4	23.5	19.7	21.6	19.1	25.1	20.4	28.5	21.5	10.1	20.2	31.3	41.0	27.7	41.9	56.7	37.8	7.3	10.9	20.4	19.8	14.8	22.5	21.9	25.7	38.8	25.6	30.5	18.9	21.0	19.4	23.2	43.6	32.1	13.5	24.6	31.8	12.2	20.9	19.0	6.2	18.0	18.8	23.2	13.1	27.1	10.0	20.6	18.6	18.5	44.3	28.0	20.7	20.0	28.2	49.8	73.3	8.7	20.8	26.3	18.3	24.0	12.1	15.3	34.2	28.4	79.5	23.1	19.3	40.5	27.7
FH		ENSG00000091483	"Fumarate hydratase"	P07954	1	241497603-241519755	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Tricarboxylic acid cycle"	Lyase	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 276.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 173.5;Early spermatids: 226.0;Syncytiotrophoblasts: 166.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017785, HPA025770, HPA025948, HPA027341"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA		1800000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222"	"unprognostic (1.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.76e-7)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.24e-2)"	43.4	75.2	30.4	31.0	33.3	31.4	37.3	33.5	42.0	28.9	43.9	66.8	68.2	36.9	26.1	51.1	27.9	23.7	179.0	33.9	33.1	101.8	276.4	26.4	30.0	31.8	31.0	24.9	38.1	95.0	31.1	32.1	32.1	33.5	69.0	58.8	42.0	38.4	213.4	40.3	59.1	42.0	32.4	30.1	53.6	44.4	32.7	31.3	34.6	229.3	40.4	37.5	33.7	33.0	129.2	105.6	97.9	89.0	93.9	110.0	154.9	155.7	121.1	171.6	107.1	152.2	78.0	81.1	100.3	119.9	75.0	178.4	151.7	115.8	148.4	93.5	48.9	76.3	102.2	131.4	84.1	180.2	66.7	80.2	70.7	96.6	108.0	60.2	107.2	175.8	236.3	101.7	126.9	64.3	156.6	120.1	104.5	186.2	223.6	127.4	107.2	365.7	167.4	107.6	125.4	108.4	131.1	153.3	104.0	67.2	117.1	120.9	106.5	76.6	98.9	137.0	264.0	90.3	103.7	97.3	85.7	203.5	112.6	11.9	22.8	4.9	16.1	33.3	21.0	27.2	18.8	15.1	46.7	25.1	22.3	21.1	1.3	18.3	29.1	23.1	23.8	16.7	30.4	33.3	33.5	42.0	33.9	33.1	31.8	31.0	32.1	32.4	32.7	33.0	17.1	38.5	30.2	9.4	25.0	20.0	24.6	69.5	17.1	24.7	19.9	17.5	173.5	35.8	40.0	23.9	14.6	101.6	13.7	44.0	78.2	60.4	226.0	25.4	23.5	18.6	18.0	37.7	12.7	45.0	58.7	25.5	26.5	25.4	19.0	24.9	13.6	80.4	50.7	35.3	14.9	40.6	48.8	18.5	14.4	37.4	23.9	23.9	24.9	8.4	27.9	35.0	10.3	8.0	14.4	29.4	35.7	26.7	41.3	19.0	66.1	86.0	29.2	39.1	39.5	27.7	67.9	84.7	47.1	32.1	18.6	166.1	14.9	48.4	74.2	22.8
IDH1		ENSG00000138413	"Isocitrate dehydrogenase (NADP(+)) 1"	O75874	2	208236229-208266074	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 536.3"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 320.2;Granulosa cells: 257.5;Hepatocytes: 328.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 768.1;RT4: 524.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033218, HPA035248, HPA057936, CAB062556"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA		16000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies, Cytosol"		"CAB033218: AB_2123166, CAB062556: AB_2665593, HPA035248: AB_10600714, HPA057936: AB_2683559"	"unprognostic (2.79e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (3.32e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.03e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.18e-3)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.69e-2)"	150.8	230.8	24.0	37.5	23.9	10.7	63.0	24.6	30.9	67.9	40.8	124.9	179.4	22.9	164.9	92.2	36.6	69.5	25.3	23.5	26.1	122.0	536.3	49.8	33.3	26.4	25.7	84.4	39.9	42.0	16.7	82.5	25.9	214.6	131.2	35.0	59.3	79.1	25.7	23.6	117.4	43.8	25.5	40.1	113.6	57.0	30.0	21.8	45.5	28.1	29.8	153.1	39.9	30.6	66.5	109.6	152.5	63.3	275.1	191.4	86.7	26.3	122.3	44.2	107.3	176.1	159.1	13.1	168.8	84.4	181.6	101.4	112.4	130.7	43.0	8.8	41.7	56.7	87.3	768.1	367.3	37.0	54.7	169.5	278.0	102.7	74.2	69.8	126.1	37.2	58.1	44.5	68.9	42.8	26.3	66.2	284.5	479.7	43.9	25.2	54.8	37.8	206.3	524.0	25.9	45.2	100.5	99.7	351.7	161.2	37.9	111.0	81.1	45.2	44.1	65.3	29.6	20.8	34.5	16.9	148.2	226.7	37.0	12.4	70.1	11.0	9.1	32.3	10.6	10.6	8.2	10.9	50.9	10.1	6.7	7.8	13.8	17.2	15.5	18.8	15.1	29.9	24.0	23.9	24.6	30.9	23.5	26.1	26.4	25.7	25.9	25.5	30.0	30.6	13.9	12.8	49.5	39.2	20.2	12.4	18.8	60.5	52.3	19.5	61.8	31.5	21.8	45.8	69.1	29.5	25.0	320.2	23.7	106.8	21.5	31.1	13.8	31.0	23.4	22.0	58.4	30.3	16.6	86.5	178.8	29.6	76.0	108.8	14.0	257.5	39.7	328.2	175.3	11.8	16.2	98.4	57.0	130.2	23.8	11.2	24.5	71.7	26.6	19.7	47.8	25.4	18.6	66.4	20.0	44.8	55.5	29.3	13.7	53.2	181.2	108.5	21.9	56.6	13.1	7.8	23.6	8.0	26.2	82.4	14.9	95.6	19.8	127.1	129.3	46.7
IDH2		ENSG00000182054	"Isocitrate dehydrogenase (NADP(+)) 2"	P48735	15	90083045-90102477	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 492.6;skeletal muscle: 1302.3;tongue: 1611.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 732.5;Distal tubular cells: 1168.0;Extravillous trophoblasts: 586.7;Syncytiotrophoblasts: 573.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 425.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007831	Enhanced		Supported	Mitochondria		NA	NA		5200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 14: REH - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA007831: AB_1851397"	"unprognostic (2.45e-2)"	"prognostic favorable (5.15e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	32.8	10.5	56.5	60.2	67.8	161.1	51.1	57.1	59.8	36.6	76.6	95.9	97.2	29.0	12.5	140.6	32.7	31.7	492.6	47.2	55.0	208.3	274.7	32.0	77.1	61.0	61.3	13.6	128.7	104.0	15.5	87.3	54.4	76.2	84.1	5.4	163.1	90.4	1302.3	61.8	84.3	79.8	52.9	36.8	175.7	5.3	71.6	148.7	16.0	1611.3	66.0	53.3	49.4	57.6	61.3	33.5	169.9	169.8	23.3	28.3	144.5	74.5	110.8	68.0	72.6	16.1	51.1	72.7	21.0	61.2	65.1	20.8	25.1	22.4	32.0	143.8	16.9	122.9	12.7	119.7	28.1	85.1	118.2	59.7	12.7	16.3	13.0	82.1	141.0	246.4	18.9	59.3	53.0	175.3	425.0	131.2	51.8	81.9	14.3	352.0	122.4	213.7	105.6	71.3	244.5	125.3	92.1	359.8	29.9	94.2	290.9	256.9	34.0	120.4	17.0	16.1	34.9	101.5	20.5	9.0	38.4	175.0	71.2	45.0	112.8	75.6	105.9	199.1	53.2	70.1	77.0	120.1	136.9	47.7	42.9	71.8	22.9	99.9	252.1	79.4	72.4	163.4	56.5	67.8	57.1	59.8	47.2	55.0	61.0	61.3	54.4	52.9	71.6	57.6	16.9	6.4	21.0	40.1	64.2	39.9	98.8	91.6	12.5	6.2	90.5	48.1	445.9	114.4	95.8	75.4	10.4	732.5	84.0	70.0	1168.0	252.8	5.6	96.4	25.7	41.6	61.7	193.8	11.8	288.8	586.7	44.7	88.2	50.9	31.6	29.2	38.2	283.1	263.7	10.1	8.3	158.3	229.9	77.7	101.1	3.2	14.0	79.0	58.7	5.6	85.3	20.9	119.4	16.6	27.3	116.6	105.0	35.3	185.9	170.3	69.6	205.0	167.9	5.4	13.1	60.8	73.4	0.6	15.6	113.3	67.1	573.0	88.1	14.7	305.1	140.1
IDH3A		ENSG00000166411	"Isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha"	P50213	15	78131498-78171945	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 99.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 144.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041465, HPA062971"	Supported		Enhanced	Mitochondria		No	No		110000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA041465: AB_10794377, HPA062971: AB_2684913"	"unprognostic (2.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (6.49e-8)"	"unprognostic (1.40e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.39e-2)"	22.6	25.1	11.5	19.9	12.6	9.7	9.6	17.0	14.7	12.4	21.4	26.2	36.6	13.7	7.8	17.0	11.0	9.0	62.5	14.8	13.2	16.8	14.2	11.9	17.1	13.0	13.1	10.8	13.0	54.7	6.9	12.1	15.2	13.9	26.7	26.2	16.2	16.1	79.4	15.8	36.0	17.1	10.1	15.3	11.9	16.9	14.3	35.0	11.2	99.7	24.8	17.7	11.1	14.8	43.8	58.5	10.4	36.5	25.5	26.1	22.6	50.8	24.5	40.6	30.5	41.6	25.8	91.6	36.8	29.9	59.9	64.2	98.2	39.3	37.0	40.7	32.2	35.7	62.4	19.2	21.8	69.8	48.8	19.9	23.6	39.4	41.2	19.3	25.7	32.0	46.4	35.9	26.0	41.4	51.4	17.4	12.9	25.2	21.8	29.3	44.4	28.1	33.4	58.3	41.4	15.8	58.2	82.1	47.1	19.1	32.7	37.4	26.4	47.6	43.9	63.1	83.1	41.5	99.9	48.8	33.2	64.9	37.7	16.9	27.9	8.3	15.1	52.9	16.4	27.7	14.7	13.5	43.5	32.6	15.2	16.4	15.5	17.3	54.8	144.4	17.7	23.2	11.5	12.6	17.0	14.7	14.8	13.2	13.0	13.1	15.2	10.1	14.3	14.8	18.0	9.6	16.5	22.9	30.6	56.0	58.7	51.4	33.0	35.1	10.9	12.6	17.5	14.3	22.6	25.8	37.5	38.3	63.0	69.0	82.2	26.1	52.2	19.9	13.4	17.5	19.2	9.4	45.9	17.9	40.4	21.2	11.7	9.2	27.3	14.5	10.8	22.4	26.5	26.9	53.3	37.6	69.2	24.9	28.6	23.4	20.8	26.4	26.6	12.2	16.0	29.3	12.3	19.6	17.9	21.5	37.9	23.7	33.2	40.6	49.6	48.1	38.2	34.6	13.1	23.8	25.5	45.7	26.2	28.4	41.2	68.4	17.7	37.2	56.0	42.0
IDH3B	RP46	ENSG00000101365	"Isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta"	O43837	20	2658395-2664219	"Citric acid cycle related proteins, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049387, HPA054180"	Supported		Enhanced	Mitochondria		NA	NA		8300	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA049387: AB_2680740, HPA054180: AB_2682407"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.83e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.39e-2)"	"prognostic favorable (6.78e-8)"	"unprognostic (8.89e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	55.6	61.3	51.8	33.4	53.0	57.9	54.7	60.8	57.9	56.6	49.4	70.8	73.9	57.3	35.9	62.4	49.8	29.6	185.8	53.8	56.3	71.0	60.5	43.9	41.9	58.0	54.0	57.7	46.0	75.3	36.8	41.1	60.0	45.7	59.7	46.1	49.1	43.1	204.0	61.9	59.9	44.7	50.6	53.1	63.7	36.6	56.6	59.5	49.4	236.6	56.5	55.5	53.4	56.0	111.6	147.4	66.0	57.9	71.3	55.9	76.0	58.2	74.0	134.5	106.7	191.4	113.4	124.5	52.2	80.4	123.7	152.7	122.9	189.0	122.6	34.7	96.7	151.2	58.4	200.6	69.7	166.5	31.8	74.4	71.5	125.9	65.7	59.2	80.4	105.6	194.9	67.7	83.0	61.1	146.1	190.4	128.3	113.4	137.9	117.7	120.2	140.2	77.7	102.5	118.5	85.5	71.9	235.0	127.3	50.8	118.1	73.0	72.4	104.2	65.4	35.8	136.3	91.2	225.3	129.8	49.1	169.9	101.2	76.0	111.7	72.2	84.9	120.8	64.5	96.3	72.8	77.7	131.9	84.6	84.6	73.1	31.4	84.8	110.9	61.2	108.1	102.1	51.8	53.0	60.8	57.9	53.8	56.3	58.0	54.0	60.0	50.6	56.6	56.0	50.7	38.5	28.2	10.4	52.1	56.7	60.2	103.8	48.9	37.9	38.5	38.2	186.0	52.9	49.5	23.9	33.3	133.9	71.3	81.7	156.5	88.5	59.3	28.2	36.0	53.7	50.7	41.6	7.0	102.1	86.3	49.2	37.2	35.9	48.2	54.1	41.7	55.4	97.6	13.5	7.6	68.4	71.2	57.7	60.9	115.1	45.1	51.7	69.4	10.3	78.7	49.3	56.7	6.6	8.9	70.8	72.5	47.4	38.1	37.5	121.7	174.9	33.4	33.4	78.9	50.0	64.1	52.8	55.3	48.4	60.0	108.5	49.1	63.4	113.7	54.3
IDH3G		ENSG00000067829	"Isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma"	P51553	X	153785766-153794523	"Citric acid cycle related proteins, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 284.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000425, HPA002017"	Supported		Approved	Nucleoli,Mitochondria		Yes	No		19000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitochondria"		"HPA000425: AB_1079097, HPA002017: AB_1079096"	"unprognostic (4.24e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.73e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.46e-1)"	52.0	67.1	45.5	38.5	50.0	60.3	49.9	47.8	61.3	44.1	46.5	57.2	52.3	50.7	23.5	50.2	44.8	35.0	91.9	54.9	48.8	68.5	49.2	42.0	40.3	50.5	45.7	49.3	48.3	45.5	47.9	28.3	52.3	43.8	34.6	24.4	51.7	39.9	100.5	51.7	54.7	34.5	43.9	51.8	52.2	32.1	49.1	35.2	48.0	82.9	34.9	44.3	43.2	47.2	94.9	90.0	47.3	65.9	74.4	59.4	62.0	47.3	64.1	80.5	84.3	76.0	66.5	121.4	80.2	74.7	68.2	67.2	72.6	69.2	30.0	38.9	101.7	43.0	118.9	59.0	85.5	61.6	87.5	76.1	48.0	64.4	69.4	50.4	65.3	50.3	24.7	60.4	64.7	138.5	72.0	76.0	21.6	84.2	118.0	62.7	43.3	105.8	94.4	61.1	59.5	42.8	30.2	96.3	48.0	20.8	39.6	51.9	56.0	49.9	34.1	76.8	112.5	89.0	22.6	152.1	81.8	75.8	57.6	178.1	159.3	165.8	71.8	163.9	68.0	68.5	73.2	71.2	163.1	78.9	57.9	63.7	57.8	86.5	169.6	101.3	107.5	140.1	45.5	50.0	47.8	61.3	54.9	48.8	50.5	45.7	52.3	43.9	49.1	47.2	44.4	35.3	33.8	5.5	49.2	80.9	67.5	103.9	37.5	34.9	48.4	57.9	55.1	50.1	55.0	51.5	29.2	99.8	48.2	145.0	207.4	93.4	132.0	42.2	39.4	44.6	62.3	41.4	5.6	90.5	98.7	48.2	47.9	39.8	93.8	43.6	43.2	35.4	131.0	18.5	6.4	107.0	79.3	98.0	77.0	284.2	53.4	75.6	67.6	3.7	116.4	50.8	64.9	3.0	5.0	73.5	133.8	58.6	49.7	35.6	222.4	253.1	50.7	49.3	52.6	47.4	68.2	15.9	18.3	50.3	77.4	110.8	55.2	103.0	112.7	64.2
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1349.1;tongue: 1843.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1926.9;Proximal tubular cells: 1428.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol		NA	NA		49000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434"	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	274.6	213.6	235.9	86.7	249.7	79.1	137.9	245.9	353.6	89.6	230.2	167.7	154.7	82.0	161.3	125.3	114.5	87.2	1349.1	253.2	261.5	371.6	266.3	89.8	131.9	248.5	218.3	80.4	69.9	411.8	107.2	92.5	253.3	125.5	190.9	240.7	122.0	142.0	792.5	87.7	133.1	171.5	215.7	71.6	192.6	70.5	259.1	170.4	125.5	1843.8	165.4	131.5	62.8	237.7	268.2	219.5	257.8	173.2	369.6	280.9	282.3	215.1	295.9	300.6	304.1	252.5	215.4	355.2	112.8	264.1	358.8	214.3	303.0	355.0	425.5	207.6	253.1	337.0	173.2	376.8	202.1	384.1	223.9	277.7	241.3	271.5	152.7	236.2	235.3	308.1	183.7	217.3	395.1	157.8	300.6	317.5	158.0	376.3	266.5	235.2	349.7	310.5	460.9	251.0	249.9	153.6	182.5	257.7	384.1	205.6	191.9	341.9	149.6	220.3	211.9	187.1	252.9	264.6	264.8	407.6	266.2	312.2	184.1	271.3	186.3	200.2	202.7	267.8	218.8	258.5	236.6	224.6	241.0	258.5	230.3	221.6	28.1	214.6	253.4	184.3	320.9	321.2	235.9	249.7	245.9	353.6	253.2	261.5	248.5	218.3	253.3	215.7	259.1	237.7	44.4	60.9	54.3	54.9	78.7	81.6	109.4	562.9	50.7	165.4	81.0	86.7	1926.9	95.8	227.2	134.3	70.9	248.7	78.4	128.4	630.0	186.2	12.4	116.1	72.6	61.0	62.8	62.9	120.2	108.1	257.0	134.7	112.7	68.8	80.5	95.0	36.0	153.2	397.0	122.8	130.0	115.9	380.5	85.2	65.8	15.1	100.0	98.4	177.9	43.1	155.0	136.3	73.2	51.3	58.8	91.3	99.8	109.1	82.1	48.8	177.4	1428.3	224.5	164.1	59.2	68.3	167.8	58.0	65.6	82.7	84.0	149.5	84.3	137.4	167.8	102.6
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 697.1;tongue: 601.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria		No	No		14000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-3)"	"unprognostic (8.94e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.70e-2)"	"prognostic favorable (1.49e-5)"	"unprognostic (8.57e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.66e-1)"	76.9	163.4	68.0	51.4	73.6	71.9	73.9	62.1	83.9	67.4	81.3	118.7	112.7	69.2	34.7	144.9	66.8	38.0	367.5	73.5	69.9	121.7	215.5	60.7	62.4	66.7	61.4	64.1	118.3	90.5	70.7	45.2	67.0	67.3	80.3	40.2	98.8	56.8	697.1	119.5	94.4	60.0	56.3	75.6	103.2	60.2	64.1	60.4	62.3	601.9	66.2	85.6	82.4	66.6	176.5	278.4	99.2	250.7	110.3	121.2	172.0	113.9	145.8	159.4	143.2	246.2	204.7	261.3	51.1	151.1	172.6	174.4	256.3	170.0	112.7	192.1	368.3	144.6	138.7	229.9	135.2	229.3	144.6	153.7	149.7	155.2	229.3	124.9	150.9	160.5	466.3	149.4	149.7	389.6	206.4	402.1	222.8	306.6	344.3	164.3	121.7	379.9	149.9	225.5	247.4	226.9	114.6	567.5	247.0	124.9	323.4	260.0	117.7	160.0	151.6	175.5	232.7	166.5	148.1	290.8	138.6	289.1	249.1	95.4	129.9	63.3	102.4	148.8	107.1	122.2	113.7	111.2	176.0	110.2	109.0	102.6	34.0	107.4	164.2	157.2	156.6	175.8	68.0	73.6	62.1	83.9	73.5	69.9	66.7	61.4	67.0	56.3	64.1	66.6	98.8	51.3	65.9	7.8	110.2	135.9	190.8	437.9	118.4	68.0	151.8	165.5	486.2	135.8	217.3	115.8	18.8	328.1	104.9	242.3	448.0	269.8	263.7	108.0	97.9	96.8	169.7	97.2	13.0	333.1	334.0	112.6	111.1	104.8	54.5	150.9	88.5	246.6	248.1	72.3	15.0	280.6	288.9	132.6	113.5	161.5	99.4	117.6	181.5	9.4	171.4	85.7	126.7	8.0	12.8	255.0	252.1	99.3	149.8	197.3	433.3	466.3	139.0	67.3	85.5	114.7	150.9	157.8	65.3	256.6	166.1	294.8	105.4	233.4	372.7	234.7
OGDH	"E1k, KGD1, OGDC-E1, OGDH2"	ENSG00000105953	"Oxoglutarate dehydrogenase"	Q02218	7	44606572-44709066	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 324.0;skeletal muscle: 363.6;tongue: 374.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019514, HPA020347"	Supported		Enhanced	Mitochondria		No	No		130000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA019514: AB_1854772, HPA020347: AB_1854773"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (2.22e-14)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.88e-3)"	64.9	67.4	35.0	39.2	39.4	32.1	32.0	42.8	45.4	33.8	119.6	56.3	95.6	40.9	16.6	61.6	34.0	26.9	324.0	34.4	50.6	89.7	39.8	43.4	40.0	44.6	44.4	24.8	27.5	99.9	34.9	33.1	44.2	37.9	41.5	25.9	43.0	46.9	363.6	56.4	87.5	51.0	35.7	39.0	52.5	36.2	43.6	32.1	54.9	374.7	41.5	42.5	37.7	35.6	35.8	73.5	42.2	66.0	63.4	69.8	41.9	54.2	51.3	59.5	50.9	67.2	71.7	156.0	63.0	79.2	119.2	108.2	85.7	81.4	58.4	92.0	22.8	47.4	140.6	33.5	32.8	59.4	51.2	66.0	60.5	85.4	60.9	43.0	82.4	50.7	55.8	45.4	63.7	50.1	59.2	34.1	39.8	97.7	81.8	55.9	30.1	175.9	68.5	104.4	73.2	35.0	78.8	107.6	34.4	75.8	64.2	58.7	66.4	43.4	38.5	76.3	64.0	40.9	84.0	85.9	78.4	65.7	80.4	9.9	21.8	12.6	17.9	28.5	19.5	11.1	20.7	18.1	22.0	9.3	8.5	10.8	12.2	19.3	35.4	10.8	42.1	23.2	35.0	39.4	42.8	45.4	34.4	50.6	44.6	44.4	44.2	35.7	43.6	35.6	19.6	6.4	22.5	49.3	23.1	19.5	12.3	15.9	22.8	21.4	14.4	18.2	114.3	12.8	14.2	47.8	18.8	24.0	20.0	64.5	31.3	14.9	51.0	26.1	15.6	16.0	23.4	32.0	43.3	16.9	16.4	20.6	35.2	38.9	21.5	15.5	17.9	22.6	33.8	62.2	53.1	32.6	12.2	24.5	43.4	24.5	11.8	33.8	21.4	29.0	22.7	14.3	16.5	22.1	36.6	20.9	38.0	17.3	27.8	16.4	82.0	51.8	17.0	24.0	19.7	24.7	20.2	10.6	19.9	28.1	26.3	36.7	27.7	30.3	33.5	18.1
OGDHL	FLJ10851	ENSG00000197444	"Oxoglutarate dehydrogenase L"	Q9ULD0	10	49734641-49762379	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 98.5;kidney: 121.8;liver: 80.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 30.4;Collecting duct cells: 29.5;Cone photoreceptor cells: 31.3;Distal tubular cells: 92.0;Hepatocytes: 55.3;Horizontal cells: 30.3;Proximal tubular cells: 84.7"	"Group enriched"	"Detected in many"	5	"liver cancer: 14.7;renal cancer: 44.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.3;RPTEC TERT1: 43.4;SH-SY5Y: 16.3;SK-BR-3: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA043716, HPA052497"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli fibrillar center"		"HPA043716: , HPA052497: AB_2681853"	"unprognostic (9.05e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.60e-1)"	"prognostic favorable (1.21e-14)"	"unprognostic (3.25e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.38e-2)"	0.2	11.6	23.1	0.3	23.4	0.0	0.0	23.7	41.1	0.7	98.5	1.4	1.0	2.2	0.5	0.1	1.0	0.4	5.8	24.4	36.9	121.8	80.0	0.0	0.2	38.4	25.6	1.6	4.3	50.5	29.3	0.1	38.9	1.6	0.3	18.7	17.1	6.3	0.1	0.1	1.1	0.7	15.4	0.3	1.0	2.3	33.8	0.5	23.0	0.8	0.6	0.5	0.5	24.3	0.0	0.0	4.7	21.3	0.0	0.0	2.7	0.1	0.1	1.1	0.2	10.5	2.3	0.0	11.4	0.0	3.4	0.4	7.4	0.2	0.4	0.0	0.4	0.0	0.2	5.3	0.2	0.0	1.6	0.3	0.0	0.0	0.0	0.6	0.0	5.4	0.5	0.0	0.0	3.2	8.2	7.3	2.0	0.8	1.0	0.0	0.0	0.0	43.4	0.7	12.0	16.3	0.1	16.2	1.1	6.1	4.5	2.9	0.0	0.0	10.6	0.0	0.7	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	23.4	23.7	41.1	24.4	36.9	38.4	25.6	38.9	15.4	33.8	24.3	0.0	0.0	0.0	20.2	0.8	0.0	0.9	0.4	0.0	30.4	0.1	0.1	4.4	2.8	0.1	29.5	31.3	0.0	0.0	0.4	92.0	1.1	0.2	0.9	0.2	0.3	4.8	0.0	16.8	0.0	0.1	0.3	0.0	1.6	0.0	0.7	1.4	55.3	0.1	30.3	21.4	0.5	2.0	1.3	0.0	0.5	0.0	0.5	0.0	1.0	0.0	5.4	0.0	3.5	1.8	0.1	1.1	0.0	0.0	0.3	0.0	84.7	0.0	18.1	0.0	0.0	0.2	0.1	2.4	0.0	0.0	0.1	0.6	0.4	0.3	0.3
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848417-66958386	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 201.9;Late spermatids: 53.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		Yes	No		200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	60.9	23.7	35.7	2.9	35.5	3.5	28.4	36.6	35.8	3.7	17.5	4.7	6.5	3.8	1.8	9.3	3.2	2.8	4.3	32.4	41.0	23.3	148.0	2.6	1.3	43.4	40.1	5.1	4.9	18.2	8.6	4.4	37.6	7.2	2.8	2.4	35.3	9.3	12.1	4.7	7.7	1.4	37.8	1.5	9.1	10.7	49.0	2.0	4.6	6.6	2.0	2.9	4.4	37.0	6.1	19.3	6.5	17.2	25.4	8.9	6.6	3.4	15.5	6.9	7.5	8.8	6.0	0.0	7.4	6.0	9.6	6.8	7.7	39.5	1.5	2.8	11.0	10.3	57.4	41.2	21.0	0.1	10.8	40.2	10.1	5.8	12.4	4.4	5.7	14.3	17.4	0.0	2.1	44.6	9.2	4.6	12.0	15.1	16.2	8.3	13.0	3.2	5.7	1.9	15.2	21.0	33.6	18.0	15.5	4.8	14.6	2.7	6.3	7.8	6.6	8.8	4.7	3.5	4.8	0.1	7.7	5.7	6.7	0.0	1.3	0.0	0.5	0.3	0.5	0.0	0.1	0.5	0.9	0.2	0.9	0.5	0.1	0.1	0.1	0.3	0.5	0.7	35.7	35.5	36.6	35.8	32.4	41.0	43.4	40.1	37.6	37.8	49.0	37.0	0.9	0.0	3.0	26.4	1.4	1.3	1.6	9.1	2.8	5.6	4.8	5.8	4.4	11.5	3.0	3.7	2.1	17.4	0.6	27.6	1.9	3.1	18.4	2.3	7.1	1.5	9.0	28.0	18.5	1.8	4.2	3.2	5.6	3.0	8.9	16.0	4.6	201.9	12.3	0.0	18.6	5.0	0.0	7.0	1.8	53.2	0.6	1.8	5.4	7.5	18.9	9.4	2.1	10.1	16.7	2.3	8.5	4.1	0.1	3.1	23.6	39.0	1.5	4.8	0.0	2.2	2.2	11.2	4.7	4.1	0.6	25.4	1.2	6.0	6.4	1.3
PCK1	PEPCK-C	ENSG00000124253	"Phosphoenolpyruvate carboxykinase 1"	P35558	20	57561080-57568121	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Kinase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 432.1;liver: 681.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 703.8;Distal tubular cells: 588.9;Hepatocytes: 1184.0;Proximal enterocytes: 2209.9;Proximal tubular cells: 3547.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 99.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"ASC diff: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006277, HPA006507, CAB017027"	Approved					NA	NA		840000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB017027: , HPA006277: AB_1079579, HPA006507: AB_1079578"	"unprognostic (3.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.60e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.43e-2)"		"unprognostic (1.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.47e-5)"	"unprognostic (1.03e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-1)"	59.2	1.1	0.8	1.7	0.8	0.0	29.8	0.7	1.6	0.0	0.6	57.8	110.4	1.2	0.2	0.4	0.9	5.0	1.0	0.7	1.4	432.1	681.4	0.2	0.3	0.7	0.9	1.6	0.4	0.0	21.1	0.3	0.8	0.2	79.8	0.5	1.1	0.2	0.4	0.9	143.9	2.9	0.6	0.3	0.9	0.0	1.3	0.1	0.8	6.5	0.0	0.8	0.1	0.8	0.0	0.0	0.0	0.0	20.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.7	1.6	0.7	1.4	0.7	0.9	0.8	0.6	1.3	0.8	0.7	0.0	0.0	0.0	21.3	0.1	0.0	0.0	15.9	0.3	0.7	0.6	1.0	61.5	0.6	90.1	0.0	0.1	0.1	703.8	588.9	0.6	0.1	1.3	1.5	2.7	53.9	40.2	0.0	0.0	0.0	2.3	19.9	8.5	8.9	0.1	29.6	1184.0	0.0	3.3	0.0	293.6	0.0	22.6	0.0	0.0	0.0	12.8	0.0	1.9	0.0	9.9	0.0	0.0	0.0	0.1	285.5	0.0	0.0	0.0	2209.9	3547.9	0.0	0.4	0.0	0.3	6.0	0.0	0.1	10.3	0.3	0.3	10.2	1.5	348.5	0.1
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"intestine: 196.1;kidney: 99.1;liver: 374.1"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 309.3;Proximal enterocytes: 752.6;Proximal tubular cells: 237.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 104.7;hTCEpi: 104.7;SK-MEL-30: 103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria		NA	NA		3500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	25.5	10.7	3.2	8.0	3.9	4.5	21.1	3.8	3.3	6.8	3.4	44.8	196.1	5.8	3.1	20.0	5.9	4.5	5.8	3.1	3.9	99.1	374.1	16.5	8.7	4.6	4.2	3.0	34.8	17.4	8.0	2.8	4.1	9.1	19.2	2.7	18.6	7.1	2.6	12.6	136.3	3.8	4.0	21.7	16.0	19.7	3.9	3.7	18.9	1.2	7.5	10.8	10.0	4.3	17.6	9.8	2.7	18.1	11.0	10.5	46.0	21.5	25.6	17.4	28.4	16.1	19.9	44.6	2.6	33.4	5.6	25.4	18.0	28.1	13.8	22.8	0.8	8.0	5.0	84.2	104.7	15.8	33.4	12.9	104.7	10.6	26.5	5.0	14.0	50.6	23.4	79.3	6.4	74.6	4.0	7.6	3.1	39.4	13.0	8.7	10.5	26.0	5.3	26.7	11.3	18.2	16.5	21.2	103.9	2.6	28.5	24.1	2.7	3.8	19.7	5.6	6.0	53.2	18.6	11.0	10.6	24.5	9.6	0.3	11.6	3.5	4.0	21.6	4.1	11.4	4.5	4.5	15.3	7.3	2.7	2.5	1.3	2.2	22.0	2.5	9.1	6.1	3.2	3.9	3.8	3.3	3.1	3.9	4.6	4.2	4.1	4.0	3.9	4.3	4.8	12.8	28.5	1.3	17.9	3.3	10.2	12.3	5.7	4.7	8.6	5.2	1.8	18.6	8.0	18.4	0.0	4.7	4.3	91.2	35.2	18.9	60.1	1.6	5.2	5.6	9.1	24.4	0.5	76.3	14.3	7.4	16.8	4.5	1.3	1.6	13.2	309.3	63.8	0.0	0.9	60.8	18.3	25.8	5.7	30.8	3.4	16.4	7.2	1.0	22.9	5.8	7.2	0.0	0.1	29.0	87.8	3.0	13.3	7.6	752.6	237.1	4.8	5.5	0.0	3.4	18.7	19.8	1.0	9.1	4.8	3.0	7.6	6.8	72.0	15.0
PDHA1	PDHA	ENSG00000131828	"Pyruvate dehydrogenase E1 subunit alpha 1"	P08559	X	19343893-19361718	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 508.8;tongue: 770.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 479.9;Distal tubular cells: 354.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"	"unprognostic (5.71e-3)"	"unprognostic (2.46e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.90e-2)"	"unprognostic (8.68e-2)"	"prognostic favorable (1.13e-7)"	"unprognostic (3.72e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.06e-2)"	93.0	69.0	62.1	37.9	66.9	88.1	63.1	66.2	91.5	55.9	84.4	112.6	87.0	53.1	78.9	76.8	49.1	29.3	508.8	68.2	67.0	174.1	118.3	47.2	36.6	64.5	62.7	50.6	83.4	161.0	48.7	43.1	65.0	48.4	104.4	90.1	109.7	63.4	459.0	60.9	82.1	51.8	59.6	49.3	121.8	24.0	67.4	52.3	64.5	770.2	59.1	61.7	56.1	71.1	124.9	151.4	107.9	114.2	102.3	77.7	131.6	83.8	74.6	170.2	130.7	216.6	78.2	212.2	60.6	102.0	226.7	159.0	334.2	145.8	178.1	70.1	186.1	104.8	264.0	194.2	107.8	170.3	82.8	100.9	132.8	157.3	154.4	85.6	105.3	129.8	94.2	87.2	120.7	164.5	142.7	173.5	110.0	227.4	261.7	145.2	180.9	260.3	298.0	125.1	59.7	62.6	134.1	167.8	158.1	229.8	177.1	118.1	65.4	87.6	78.6	240.9	108.6	73.3	82.0	140.5	82.4	117.2	77.4	99.9	87.4	65.3	72.3	119.9	88.9	103.4	69.4	79.5	115.7	82.1	67.7	72.0	15.5	98.1	109.1	76.9	84.4	89.6	62.1	66.9	66.2	91.5	68.2	67.0	64.5	62.7	65.0	59.6	67.4	71.1	34.1	44.8	44.4	18.6	30.7	29.8	59.7	135.4	25.0	59.0	37.0	29.3	479.9	87.2	74.8	152.6	33.3	105.0	32.5	73.0	354.1	88.8	2.5	41.2	33.7	36.8	41.9	55.8	21.2	59.8	120.7	49.2	49.5	36.9	42.6	39.7	18.2	76.3	73.2	25.2	24.6	64.4	71.2	26.8	30.5	4.1	35.4	32.5	56.9	9.4	40.8	49.0	26.8	13.0	11.5	47.4	52.5	40.6	43.3	47.1	88.6	213.7	33.1	69.1	32.9	37.5	51.7	51.1	25.3	45.2	33.4	133.4	31.6	25.4	130.3	55.8
PDHA2	PDHAL	ENSG00000163114	"Pyruvate dehydrogenase E1 subunit alpha 2"	P29803	4	95840093-95841464	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	602	"testis: 60.2"	"Group enriched"	"Detected in some"	71	"Early spermatids: 426.6;Late spermatids: 288.3;Spermatocytes: 229.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria		NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	426.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	288.3	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	229.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDHB	PDHE1B	ENSG00000168291	"Pyruvate dehydrogenase E1 subunit beta"	P11177	3	58427630-58433857	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 299.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 300.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033794, HPA036744, HPA036745"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		61000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.79e-8)"	"unprognostic (2.67e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.85e-2)"	59.9	76.5	48.7	42.2	50.2	25.7	42.9	53.9	62.7	43.3	63.6	56.8	42.5	38.5	44.6	57.4	37.7	35.9	175.0	49.7	52.3	100.8	110.7	36.4	53.1	51.7	49.4	26.5	36.4	88.8	44.1	57.0	51.5	48.5	60.4	30.7	45.9	52.1	272.6	36.8	37.6	63.8	51.6	42.8	53.9	42.3	53.1	53.1	40.8	299.4	56.0	49.7	35.9	54.3	66.5	90.9	92.3	69.8	91.7	111.1	110.4	81.6	101.3	117.9	120.6	165.1	62.6	140.3	44.9	103.8	109.0	37.6	113.2	74.9	90.0	81.7	83.0	125.4	163.7	126.0	92.5	103.0	67.9	97.9	67.7	95.5	55.8	137.5	103.1	114.2	65.9	61.5	129.5	63.1	98.2	107.8	127.2	69.2	101.3	46.3	71.8	136.1	188.1	89.1	63.7	70.2	75.6	107.2	85.4	131.3	159.0	108.7	76.3	62.9	83.7	66.8	94.2	85.2	129.9	99.2	96.2	120.8	60.7	57.8	98.9	98.7	83.2	115.1	87.9	102.2	81.7	80.5	141.1	103.4	90.9	82.4	19.6	129.4	109.7	94.7	113.2	124.1	48.7	50.2	53.9	62.7	49.7	52.3	51.7	49.4	51.5	51.6	53.1	54.3	57.8	60.9	34.5	5.9	45.3	27.9	40.7	142.0	26.7	31.8	29.4	31.6	300.6	48.6	96.0	35.0	25.0	174.1	35.3	41.0	230.9	95.9	76.3	37.0	37.3	58.0	58.0	22.5	10.9	72.2	101.6	54.1	29.6	34.2	39.3	48.5	46.1	76.1	84.6	57.2	13.3	50.4	162.8	37.9	26.6	16.9	60.3	37.2	56.9	9.4	76.5	61.7	70.0	9.0	13.6	55.9	43.0	51.1	38.8	19.1	45.8	146.8	70.7	45.9	65.7	30.8	72.3	98.2	88.3	42.8	29.8	157.2	44.7	224.4	53.0	37.7
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-257082	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 601.0;skeletal muscle: 479.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria		No	No		360000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavorable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	70.6	148.0	60.5	29.6	62.7	38.4	65.8	78.7	71.3	50.2	63.2	131.9	148.9	53.2	27.3	67.1	50.3	33.9	601.0	60.8	73.4	139.1	276.8	54.3	43.1	74.1	62.7	65.8	71.5	122.9	44.8	28.8	75.7	46.3	82.1	42.7	66.8	35.6	479.0	58.9	116.8	36.1	61.7	66.4	115.6	56.4	71.7	41.8	49.6	224.8	36.5	63.2	56.3	63.7	88.4	154.2	54.8	95.0	96.9	68.5	154.1	63.3	81.8	107.2	108.4	163.9	115.9	108.3	218.6	70.2	92.1	111.8	102.4	129.7	66.3	241.9	98.9	50.1	390.8	224.1	60.0	69.5	70.7	70.6	84.3	83.6	33.7	93.6	123.9	83.5	84.6	83.1	48.7	155.8	93.9	206.9	19.3	101.4	193.5	119.0	84.6	223.2	245.4	122.7	62.3	35.4	332.5	205.5	90.7	36.1	115.0	93.2	91.1	80.3	82.1	48.2	52.5	93.0	40.9	79.8	81.6	99.9	52.5	66.6	70.8	88.1	95.2	85.7	86.8	79.5	92.5	94.5	93.3	73.3	89.2	85.0	14.1	85.5	74.7	59.5	149.3	111.3	60.5	62.7	78.7	71.3	60.8	73.4	74.1	62.7	75.7	61.7	71.7	63.7	29.4	35.3	71.1	20.2	50.9	61.2	81.4	105.8	31.3	51.0	24.6	17.0	272.6	64.3	78.5	75.4	102.2	109.6	39.3	169.7	142.8	94.7	58.7	39.1	30.1	39.1	47.5	56.8	34.4	44.9	102.8	49.4	47.9	48.5	43.7	64.8	47.5	167.0	67.5	101.0	39.9	96.3	105.8	41.0	55.0	28.8	68.3	38.8	90.7	12.2	60.2	50.7	52.5	19.1	37.9	54.2	100.1	55.7	67.5	37.0	274.4	190.7	75.2	87.2	78.9	33.2	51.7	96.9	54.3	40.9	35.9	154.7	56.7	85.0	160.1	88.2
SDHB	"SDH, SDH1"	ENSG00000117118	"Succinate dehydrogenase complex iron sulfur subunit B"	P21912	1	17018722-17054032	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 491.5;tongue: 580.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 405.5;Proximal tubular cells: 449.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002868, CAB009822, CAB068233, CAB068234, CAB068235"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"	"Intracellular and membrane"	NA	NA		7900	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Plasma membrane"	"CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889"	"unprognostic (1.06e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (1.46e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.82e-2)"	85.8	95.7	68.0	59.0	72.2	94.6	68.7	80.6	84.3	56.8	81.1	134.3	163.0	56.0	71.0	77.4	59.8	48.0	302.8	69.9	76.9	228.0	336.1	56.1	75.3	74.8	71.4	44.4	80.3	144.3	42.8	57.6	73.8	55.7	132.4	62.9	74.0	60.5	491.5	55.6	121.9	70.4	73.9	60.5	92.8	64.4	74.9	62.7	64.3	580.6	84.2	71.3	52.0	78.9	157.3	152.7	72.2	107.8	141.6	135.2	95.9	122.4	145.2	254.3	227.7	216.8	183.1	206.8	159.3	156.4	176.1	180.1	290.7	226.8	284.8	128.7	280.6	183.4	149.2	168.2	172.8	276.0	135.6	140.4	154.9	224.5	370.1	138.7	183.6	176.5	165.2	236.9	179.6	129.5	182.4	175.1	70.4	224.6	302.6	146.1	142.5	265.4	252.4	88.7	157.5	86.0	172.3	216.3	392.3	76.4	131.1	169.1	94.9	115.8	131.0	206.4	176.0	98.9	133.3	198.6	170.4	438.5	128.3	68.7	149.8	149.5	71.4	206.5	70.7	89.9	81.0	77.5	186.8	81.1	73.5	74.8	174.3	85.3	185.7	89.3	113.8	116.1	68.0	72.2	80.6	84.3	69.9	76.9	74.8	71.4	73.8	73.9	74.9	78.9	48.2	64.1	47.4	20.9	57.4	52.1	93.3	199.8	40.5	31.5	45.2	49.4	405.5	101.5	97.0	47.8	14.6	107.1	48.3	176.1	354.1	134.3	220.3	48.7	38.2	54.7	48.6	77.3	27.7	149.2	142.2	62.0	46.9	45.5	66.6	39.9	46.8	226.0	177.4	37.0	32.1	103.1	116.0	88.7	67.9	30.5	57.8	78.4	64.0	29.0	123.1	78.3	48.4	15.6	24.6	111.5	218.3	67.7	62.2	74.4	300.5	449.0	79.8	53.8	39.5	57.1	191.6	148.9	71.5	72.9	54.6	121.8	46.8	69.3	162.0	110.9
SDHC	"CYB560, cybL, PGL3"	ENSG00000143252	"Succinate dehydrogenase complex subunit C"	Q99643	1	161314381-161363206	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 776.7;Proximal tubular cells: 916.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.48e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.19e-3)"	"unprognostic (3.77e-1)"	128.9	143.7	73.7	64.1	79.7	60.5	100.3	84.5	85.1	78.7	92.9	118.9	127.8	70.9	76.0	109.7	98.6	63.3	154.1	68.4	83.4	285.7	319.4	65.5	74.7	78.8	79.1	69.2	62.5	173.6	52.4	73.1	76.7	77.3	132.2	84.3	74.8	84.7	277.4	69.8	101.4	101.4	85.1	62.8	89.9	52.7	84.8	93.1	89.5	288.4	105.1	88.4	61.3	85.6	161.1	129.7	157.5	147.7	248.3	213.3	196.3	150.9	190.3	180.3	137.3	185.4	208.7	53.7	190.6	214.8	121.6	178.5	244.3	214.2	193.2	185.6	205.6	110.2	106.6	196.7	126.9	193.8	109.1	211.5	181.7	174.3	119.4	167.9	177.5	164.0	178.9	43.8	266.3	167.0	152.4	112.5	145.4	376.3	123.7	131.6	151.0	217.1	330.3	167.8	118.3	180.7	211.0	385.1	225.4	207.9	342.1	259.3	133.5	103.7	125.1	127.9	147.3	173.3	287.8	269.4	140.3	139.2	193.6	88.6	111.0	65.7	76.6	99.6	79.6	68.6	66.2	75.4	136.1	65.7	71.2	71.0	52.0	66.9	87.5	100.6	78.3	130.0	73.7	79.7	84.5	85.1	68.4	83.4	78.8	79.1	76.7	85.1	84.8	85.6	50.9	44.8	59.4	14.7	70.1	61.8	151.2	342.6	59.7	74.9	81.4	58.3	94.0	131.5	163.5	150.8	64.6	248.0	65.5	95.9	776.7	218.4	18.6	87.1	63.8	80.7	66.8	81.4	19.3	145.2	248.5	79.8	79.5	62.6	58.3	66.6	83.2	249.1	237.3	72.3	27.4	103.4	215.7	100.6	74.4	34.7	102.9	94.6	129.9	9.4	176.1	107.8	107.1	17.6	24.5	142.7	89.5	109.1	71.9	100.2	139.1	916.5	177.9	69.3	52.6	74.5	94.4	115.3	114.4	111.2	76.4	307.6	72.0	215.7	154.2	155.0
SDHD	"cybS, PGL, PGL1"	ENSG00000204370	"Succinate dehydrogenase complex subunit D"	O14521	11	112086824-112120016	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"		"Cancer-related genes, Disease variant, FDA approved drug targets, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 530.2;Proximal tubular cells: 449.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA045727	Approved				"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA045727: AB_10963114"	"unprognostic (9.13e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.83e-3)"	"unprognostic (7.10e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.99e-10)"	"unprognostic (5.14e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.51e-2)"	117.5	95.7	60.0	84.5	63.1	72.9	102.6	68.6	76.3	92.5	65.1	185.2	208.1	88.2	96.7	126.7	92.6	85.6	254.7	60.1	65.4	319.9	391.8	79.3	131.7	63.4	62.5	91.6	77.8	152.4	37.0	95.0	63.2	87.9	190.8	37.4	112.6	100.9	354.7	64.3	175.6	98.1	64.7	85.1	101.1	34.1	63.7	102.5	136.8	449.6	124.8	117.9	76.4	68.2	84.0	67.3	58.1	89.4	212.0	170.7	97.3	97.5	147.6	106.8	132.2	244.8	222.1	155.5	288.4	131.0	156.1	203.5	175.4	139.8	129.8	129.9	92.4	142.8	51.9	140.1	165.6	222.4	107.5	189.6	160.2	110.5	189.1	124.6	153.0	109.6	156.0	208.7	135.0	95.2	143.9	215.0	77.4	333.8	211.6	126.2	145.8	294.4	221.6	175.2	83.5	55.8	135.3	194.8	107.0	81.8	198.9	164.2	108.0	103.8	132.3	114.7	95.0	59.1	73.2	270.7	58.8	297.0	100.5	233.7	293.3	208.8	158.4	390.1	173.1	235.2	170.8	168.8	308.7	198.1	204.3	191.8	257.5	207.9	322.9	151.7	189.9	348.9	60.0	63.1	68.6	76.3	60.1	65.4	63.4	62.5	63.2	64.7	63.7	68.2	104.3	80.1	51.1	12.4	78.0	81.6	102.2	262.2	83.6	12.2	61.0	78.4	216.5	120.1	108.1	90.1	8.4	154.3	55.2	203.8	530.2	82.9	9.9	41.6	67.6	76.4	50.4	70.2	9.6	58.9	124.1	104.6	75.4	41.2	65.9	32.3	76.8	169.7	162.9	11.8	11.2	129.1	154.6	97.1	74.4	37.0	104.1	94.2	76.5	9.4	118.6	52.9	75.2	8.0	9.7	54.1	134.2	99.6	80.9	61.6	253.1	449.9	60.5	18.9	92.1	78.3	110.7	70.4	55.8	127.1	74.4	179.0	71.4	86.2	176.0	98.6
SUCLA2	LINC00444	ENSG00000136143	"Succinate-CoA ligase ADP-forming subunit beta"	Q9P2R7	13	47745736-48037968	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 232.2;tongue: 271.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 256.2;Late spermatids: 314.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039435, HPA039536, HPA061528"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553"	"unprognostic (5.66e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.59e-14)"	"unprognostic (3.53e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.22e-4)"	53.9	40.6	28.4	20.2	30.8	13.6	38.7	36.6	39.2	32.4	33.6	37.1	58.2	27.2	24.8	33.1	24.7	20.3	100.2	30.7	38.2	77.5	29.0	18.2	22.0	30.6	30.0	30.9	25.4	71.2	20.4	28.1	32.3	35.8	36.3	44.2	33.9	31.3	232.2	20.5	44.7	33.1	30.6	19.9	29.7	17.9	33.8	30.7	36.4	271.9	23.9	26.0	25.3	35.1	44.9	49.5	60.6	37.1	68.4	51.3	38.9	64.8	72.4	66.9	44.5	91.3	47.9	61.3	49.3	63.9	39.9	60.0	81.9	61.9	81.6	59.8	75.9	69.2	45.8	58.0	47.6	69.9	38.9	48.4	71.2	45.3	52.6	54.4	49.0	70.7	47.7	21.1	65.8	31.4	73.1	80.8	64.4	150.2	64.7	60.9	55.4	49.3	94.4	41.9	34.7	41.2	54.5	49.3	39.1	66.5	43.8	60.8	39.0	36.2	24.1	53.0	45.7	23.0	37.4	72.7	22.8	50.9	54.8	12.6	50.2	27.8	34.4	53.7	41.9	34.6	38.0	42.2	62.5	33.1	47.7	47.5	8.8	51.8	46.1	49.8	46.6	36.5	28.4	30.8	36.6	39.2	30.7	38.2	30.6	30.0	32.3	30.6	33.8	35.1	20.8	25.6	16.8	17.6	20.1	32.4	37.7	57.5	21.1	44.8	28.9	26.5	148.8	17.2	40.2	31.3	12.5	48.7	18.1	29.1	164.4	32.3	256.2	50.9	32.0	22.0	19.2	21.0	37.0	17.8	42.7	37.7	19.9	52.6	33.7	25.2	16.1	14.7	29.9	45.4	39.0	19.5	71.2	16.7	20.4	314.2	37.0	21.7	42.7	21.5	24.9	43.3	13.4	26.2	38.2	20.2	30.6	46.3	22.1	35.9	62.3	127.4	29.9	42.4	39.5	33.3	50.0	36.3	29.0	22.8	31.7	52.1	19.7	47.3	30.4	39.0
SUCLG1		ENSG00000163541	"Succinate-CoA ligase GDP/ADP-forming subunit alpha"	P53597	2	84423528-84460045	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 554.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 935.2;Proximal enterocytes: 647.5;Proximal tubular cells: 2949.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036683, HPA036684"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA		350000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Plasma membrane, Cytosol"	"HPA036683: AB_10671708, HPA036684: AB_2675248"	"unprognostic (6.84e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.21e-8)"	"unprognostic (4.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	118.7	73.3	70.6	43.1	73.2	48.2	80.0	76.2	92.5	49.9	91.1	156.9	231.1	42.4	78.8	86.9	54.6	41.9	258.1	71.1	74.5	554.0	193.0	41.6	47.8	71.7	70.2	45.7	93.6	244.2	46.8	48.8	72.9	54.3	165.9	38.4	120.6	66.6	274.1	55.4	195.4	63.5	73.8	39.6	81.1	36.9	73.3	61.7	97.6	368.1	63.1	66.4	58.5	76.9	90.2	94.9	73.8	91.1	137.8	91.2	127.7	98.4	85.2	126.0	91.2	224.5	72.0	122.4	67.0	119.8	100.2	126.8	156.7	118.4	149.8	119.3	141.4	105.9	75.4	129.2	116.0	110.6	82.7	109.1	95.6	106.3	143.7	76.7	115.1	97.9	110.1	98.1	117.5	137.4	158.2	101.1	39.4	334.1	170.0	98.3	172.6	134.5	172.2	106.4	89.8	49.3	78.9	163.7	162.3	69.0	99.8	85.4	93.1	96.6	94.6	119.9	124.9	84.2	131.0	107.8	113.9	150.4	88.0	101.6	91.0	80.8	79.0	110.2	88.5	70.2	72.0	88.4	115.4	55.4	79.1	84.3	49.7	102.3	114.3	63.2	107.7	142.7	70.6	73.2	76.2	92.5	71.1	74.5	71.7	70.2	72.9	73.8	73.3	76.9	52.7	64.1	96.5	32.7	61.0	35.4	108.9	129.6	44.3	33.3	105.0	109.1	408.6	131.5	115.2	141.6	22.9	232.3	49.9	218.1	935.2	131.8	49.2	67.1	56.9	57.0	106.3	68.4	45.8	113.2	129.3	69.8	79.5	80.8	91.3	46.0	57.5	210.0	131.7	45.4	43.5	202.1	105.8	71.3	46.0	35.9	54.7	82.2	119.2	16.9	89.8	68.2	58.7	28.1	46.2	67.1	215.4	74.1	57.1	64.2	647.5	2949.2	83.7	36.1	52.6	61.1	98.3	138.9	54.4	111.3	41.3	188.4	64.4	90.7	388.7	111.0
SUCLG2		ENSG00000172340	"Succinate-CoA ligase GDP-forming subunit beta"	Q96I99	3	67360460-67654612	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 278.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 402.3;Proximal tubular cells: 354.4;Undifferentiated cells: 306.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046705, HPA051998"	Enhanced		Approved	"Plasma membrane,Mitochondria"		NA	NA		300000	"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Plasma membrane"	"HPA046705: AB_2679762, HPA051998: AB_2681687"	"unprognostic (1.69e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.59e-2)"	"prognostic favorable (2.79e-10)"	"unprognostic (3.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.38e-1)"	66.7	44.9	16.1	36.7	17.9	18.6	48.7	17.1	19.6	42.1	22.4	169.7	136.6	32.6	32.2	50.5	39.1	48.4	85.5	14.2	17.6	147.3	278.0	34.0	39.3	19.0	17.3	39.0	47.8	34.6	10.2	28.1	19.5	49.3	146.1	7.3	46.8	42.3	154.0	26.1	132.2	40.0	17.7	44.8	110.6	10.4	18.1	24.7	49.3	130.6	35.5	39.3	24.0	18.8	43.8	37.4	36.3	44.6	59.7	102.5	44.2	51.3	74.4	58.9	65.4	41.7	95.1	55.7	16.3	72.5	38.8	22.0	28.5	70.8	75.9	23.8	19.5	50.5	31.2	65.5	76.8	67.2	33.9	77.3	60.3	46.2	105.2	73.0	63.6	41.8	39.1	49.5	129.9	30.6	25.5	21.2	34.1	199.2	23.0	17.6	56.1	83.8	100.0	66.9	7.1	24.5	81.5	92.7	68.8	24.3	71.6	42.5	55.9	58.2	38.2	64.5	61.8	33.4	52.2	39.0	85.5	51.6	70.0	17.3	36.3	13.0	30.8	44.3	37.6	45.5	44.6	39.5	24.6	42.5	68.4	53.1	1.6	68.0	37.4	9.8	45.4	48.5	16.1	17.9	17.1	19.6	14.2	17.6	19.0	17.3	19.5	17.7	18.1	18.8	40.2	35.3	50.8	66.6	48.5	37.1	44.7	38.9	21.1	2.9	54.1	29.1	172.0	84.4	51.7	80.9	8.4	55.4	31.7	223.5	244.6	85.1	3.2	49.6	43.4	40.1	58.2	17.2	6.2	80.9	44.9	47.5	90.7	46.8	30.4	31.4	45.0	402.3	56.5	5.0	5.3	212.1	40.7	68.6	49.2	5.4	41.3	36.3	42.7	90.9	35.5	29.2	36.0	72.4	60.0	59.2	164.0	47.4	30.3	41.2	222.2	354.4	58.7	4.5	32.9	41.6	50.5	1.6	6.3	55.6	49.3	38.0	48.6	78.5	306.6	50.9
